Content Area

Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R.

Brand name(s)

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Briggs GG, Freeman RK, Yaffe SJ, editors.

Study Name	Sample Size	Dose Administered	Outcome Measured	Results
Women's ED Study 1	150 women	10 mg daily	Sexual satisfaction, libido score	Improved scores in treatment group
Female Sexual Function Trial	200 women	5-20 mg	Erectile-related response, libido	Variable, some side effects observed
Tadalafil Safety in Women	100 women	10 mg	Adverse events	Mild headaches, flushing

A reference guide to fetal and neonatal risk: drugs in pregnancy and lactation 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p.

Aspect	Feedback from Users	Common Concerns
Efficacy	Some report improved sexual satisfaction	Mixed results, placebo effect possible
Side effects	Mild headaches, flushing reported	Worry about adverse effects
Accessibility	Often limited to trials or off-label use	Cost and regulation issues
Desire for more research	Strong demand for more data	Lack of official approval

v11-xxiv. Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients.

Product	Dosage	Quantity + Bonus	Price
Cialis Generic	2.5mg	180 + 10 Pills	154.86€ 147.49€	Buy
Cialis Generic	2.5mg	90 + 6 Pills	112.43€ 107.08€	Buy
Cialis Generic	60mg	270 + 10 Pills	443.96€ 422.82€	Buy
Tadalista Super Active	20mg	30 + 6 Pills	128.09€ 121.99€	Buy
Cialis Generic	10mg	30 + 4 Pills	63.32€ 60.30€	Buy
Cialis Generic	5mg	10 Pills	29.39€ 27.99€	Buy
Tadalista Super Active	20mg	180 + 20 Pills	521.59€ 496.75€	Buy
Cialis Generic	5mg	90 + 6 Pills	115.91€ 110.39€	Buy
Cialis Generic	20mg	360 + 10 Pills	427.34€ 406.99€	Buy
Cialis Generic	2.5mg	360 + 10 Pills	260.03€ 247.65€	Buy
Cialis Generic	40mg	30 + 4 Pills	74.97€ 71.40€	Buy
Cialis Generic	40mg	90 + 6 Pills	171.35€ 163.19€	Buy

Caruso S, Intelisano G, Lupo L, Agnello C. Premenopausal women affected by arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. BZ371A 2.5 mg (0.5 ml) BZ371A 7.5 mg (1.5 ml) Women between the ages 21 and 60; Women between the ages 21 and 60; Pre-menopausal or post-menopausal women may be included; Pre-menopausal or post-menopausal women may be included; May or may not be taking female sex hormones (estrogen with or without progesterone,or their derivatives); May or may not be taking female sex hormones (estrogen with or without progesterone,or their derivatives); FSAD, defined as the inability, persistent or recurrent, to obtain or maintain untilthe conclusion of sexual activity an adequate genital response to sexual arousal (lubrication, warmth and enlargement of the clitoris); FSAD, defined as the inability, persistent or recurrent, to obtain or maintain untilthe conclusion of sexual activity an adequate genital response to sexual arousal (lubrication, warmth and enlargement of the clitoris); Women with FSAD who present marked suffering or interpersonal difficulties; Women with FSAD who present marked suffering or interpersonal difficulties; Stable relationship for more than 6 months, with a sexually active partner; Stable relationship for more than 6 months, with a sexually active partner; Ability to read and understand the Informed Consent Form (ICF) and to answer thequestionnaires.

Use	Description	Evidence Level
Female Sexual Dysfunction	To improve libido and arousal	Experimental, some positive reports
Vestibular Disorders	To enhance blood flow in inner ear	Limited data
Pulmonary Hypertension	To reduce pulmonary artery pressure	Off-label, under clinical study

Ability to read and understand the Informed Consent Form (ICF) and to answer thequestionnaires. Women who do not agree to use a contraceptive method and who have the capacity tobecome pregnant during the study; Women who do not agree to use a contraceptive method and who have the capacity tobecome pregnant during the study; Women who do not agree to attempt sexual activity at least twice a week while takingthe study medication; Women who do not agree to attempt sexual activity at least twice a week while takingthe study medication; History of unresolved sexual trauma or abuse; History of unresolved sexual trauma or abuse; Diagnosis of vaginismus, genitopelvic pain/penetration disorder and/or sexualaversion disorder; Diagnosis of vaginismus, genitopelvic pain/penetration disorder and/or sexualaversion disorder; Uncontrolled diabetes at screening visit (HbA1C > 10%); Uncontrolled diabetes at screening visit (HbA1C > 10%); Prior spinal cord injury, with lower limb paralysis; Prior spinal cord injury, with lower limb paralysis; History of abdominal or pelvic surgery that may have damaged pelvic nerves,including vulvectomy, colostomy, cytostomy, hysterectomy, or bladder suspension. History of abdominal or pelvic surgery that may have damaged pelvic nerves,including vulvectomy, colostomy, cytostomy, hysterectomy, or bladder suspension. Current testosterone use, or long-term testosterone use (such as chip) within thepast 6 months; Current testosterone use, or long-term testosterone use (such as chip) within thepast 6 months; Presence of menstrual irregularity or endocrinopathies that significantly alter themenstrual cycle, preventing Cytocam analyses from taking place at the same time; Presence of menstrual irregularity or endocrinopathies that significantly alter themenstrual cycle, preventing Cytocam analyses from taking place at the same time; Patients with current depression, characterized by the use or need for use ofpsychotropic drugs, including bupropion, lithium, or neuroleptics; Patients with current depression, characterized by the use or need for use ofpsychotropic drugs, including bupropion, lithium, or neuroleptics; Presence of genital lesions that impair analysis of local adverse effects on thegenitalia; Presence of genital lesions that impair analysis of local adverse effects on thegenitalia; Presence of diseases that cause excessive vaginal discharge, such as recurrenturinary tract infection, vaginal infection and pelvic inflammatory disease. Presence of diseases that cause tadalafil sale excessive vaginal discharge, such as recurrenturinary tract infection, vaginal infection and pelvic inflammatory disease. Abnormal Papanicolaou test within the past 3 years; Abnormal Papanicolaou test within the past 3 years; History of gynecological cancer (history of uterine dysplasia can be included,provided it has been properly treated for at least 6 months); History of gynecological cancer (history buy tadalafil of uterine dysplasia can be included,provided it has been properly treated for at least 6 months); Use of topical medications in the genital region that may interfere with PSIassessment as well as their absorption or drug interaction, including vaginalestrogens, lubricants, spermicides, creams or gels, vaginal douches; Use of topical medications in the genital region that may interfere with PSIassessment as well as their absorption or drug interaction, including vaginalestrogens, lubricants, spermicides, creams or gels, vaginal douches; History of symptomatic hypotension, or diseases that increase the risk ofsymptomatic hypotension, such as patient with heart disease (including history ofangina and/or heart failure) and nephropathies; History of symptomatic hypotension, or diseases that increase the risk ofsymptomatic hypotension, such as patient with heart disease (including history ofangina and/or heart failure) and nephropathies; Current use of nitrates, such as propatylnitrate (Sustrate®), isosorbide (Monocordil®, Cincordil®, Isordil®), nitroglycerin (Nitradisc®, Nitroderm TTS®,Nitronal®, Tridil®) and sosorbitol dinitrate (Isocord®) Current use of nitrates, such as propatylnitrate (Sustrate®), isosorbide (Monocordil®, Cincordil®, Isordil®), nitroglycerin (Nitradisc®, Nitroderm TTS®,Nitronal®, Tridil®) and sosorbitol dinitrate (Isocord®) ECG findings that are clinically symptomatic, or that, in the Investigator'sjudgment, are considered significant and pose a risk to the research volunteer'sparticipation; ECG findings that are clinically symptomatic, or that, in the Investigator'sjudgment, are considered significant and pose a risk to the research volunteer'sparticipation; Findings on laboratory tests that, in the Investigator's judgment, are consideredsignificant and offer risk to the research volunteer's participation or may hinderthe study analyses; Findings on laboratory tests that, in the Investigator's judgment, are consideredsignificant and offer risk to the research volunteer's participation or may hinderthe study analyses; TSH outside normal limits for age (participants with hypothyroidism on stable doseof medication, over 3 months, may be included); TSH outside normal limits for age (participants with hypothyroidism on stable doseof medication, over 3 months, may be included); BP outside safe limits: SBP below 90 mmHg or above 170 mmHg; or DBP below 50 mmHg orabove 100 mmHg, except for situations such as "white coat" syndrome BP outside safe limits: SBP below 90 mmHg or above 170 mmHg; or DBP below 50 mmHg orabove 100 mmHg, except for situations such as "white coat" syndrome Severe hypertension, considered as use of three or more antihypertensives; Severe hypertension, considered as use of three or more antihypertensives; Diseases that can cause clitoral priapism, such as sickle cell anemia, multiplemyeloma or leukemia; Diseases that can cause clitoral priapism, such as sickle cell anemia, multiplemyeloma or leukemia; Current relevant diarrhea, defined as duration over four weeks, association withabdominal pain or malabsorptive syndrome, or presence of mucus, pus, or blood in thestool; Current relevant diarrhea, defined as duration over four weeks, association withabdominal pain or malabsorptive syndrome, or presence of mucus, pus, or blood in thestool; Current use of nitric oxide donors, guanylate cyclase stimulators (e.g.

Frequently Asked Questions (FAQs) about Cialis for Women

Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Briggs GG, Freeman RK, Yaffe SJ, editors. A reference guide to fetal and neonatal risk: drugs in pregnancy and lactation 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2002.

Tadalafil for female sexual dysfunction

p. v11-xxiv. Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients. Caruso S, Intelisano G, Lupo L, Agnello C. Premenopausal women affected by arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. Riociguat),or 5- phosphodiesterase inhibitors (Sildenafil, Tadalafil, etc.); Any disease or condition or physical finding that the Investigator considerssignificant and that increases the risk of the research participant's participationor may interfere with the results, including serious debilitating diseases, presenceof cancer, serious mental illness, persistent abuse of medication.

• Tadalafil has been studied for use in women with diabetic sexual dysfunction.
• Some reports suggest improved functionality with daily use.
• It is being evaluated for postpartum sexual health issues.
• Female-specific studies include subjective sexual satisfaction assessments.
• Tadalafil's use in women remains an off-label option.
• Side effects in women tend to be mild but should be monitored.
• It may benefit women experiencing vaginal dryness due to blood flow issues.
• Weekly or as-needed dosing strategies are under investigation.
• Women interested should seek specialized medical advice.

Any disease or condition or physical finding that the Investigator considerssignificant and that increases the risk of the research participant's participationor may interfere with the results, 10mg tadalafil including serious debilitating diseases, presenceof cancer, serious mental illness, persistent abuse of medication. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you. Tadalafil may help some women ages 30 to 45 who have physical arousal issues like reduced lubrication or sensitivity, especially when related to blood flow, diabetes, or antidepressants.

What to avoid

Tadalafil may help some women ages 30 to 45 who have physical arousal issues like reduced lubrication or sensitivity, especially when related to blood flow, diabetes, or antidepressants. It is not FDA approved for female sexual dysfunction, the evidence is mixed, and safety considerations and drug interactions mean you should only use it under a clinician’s guidance. There are several factors to consider, including perimenopausal hormones, alternative treatments, contraindications, and what to ask your doctor. See below for full benefits, risks, and specific next steps. Discover if tadalafil symptoms need careLearn likely causes of your symptomsSee if it could be tadalafil side effectsFind OTC relief for common symptomsFind a doctor for side effectsDiscover medically proven home remediesUnderstand what symptoms mean for you When most people hear the word tadalafil, they think of erectile dysfunction in men.

What happens to muscle gains after stopping tadalafil?

It is not FDA approved for female sexual dysfunction, the evidence is mixed, and safety considerations and drug interactions mean you should only use it under a clinician’s guidance. There are several factors to consider, including perimenopausal hormones, alternative treatments, contraindications, and what to ask your doctor.

Research on tadalafil’s effects in women

Drug interactions and contraindications

See below for full benefits, risks, and specific next steps.

• Tadalafil's role in female sexual health is promising but unconfirmed.
• It may be used alongside counseling for better outcomes.
• The medication helps enhance blood flow to the clitoris and labia.
• Not recommended as a first-line treatment for women.
• Tadalafil research involves small sample sizes so far.
• Its use in women is increasingly accepted in clinical trials.
• Women should discuss potential risks with healthcare providers.
• It is available in some countries specifically for research use.
• Further evidence needed to recommend widespread use.

Discover if tadalafil symptoms need careLearn likely causes of your symptomsSee if it could be tadalafil side effectsFind OTC relief for common symptomsFind a doctor for side effectsDiscover medically proven home remediesUnderstand what symptoms mean for you When most people hear the word tadalafil, they think of erectile dysfunction in men.

Abstract Abstract

BZ371A 2.5 mg (0.5 ml) BZ371A 7.5 mg (1.5 ml) Women between the ages 21 and 60; Women between the ages 21 and 60; Pre-menopausal or post-menopausal women may be included; Pre-menopausal or post-menopausal women may be included; May or may not be taking female sex hormones (estrogen with or without progesterone,or their derivatives); May or may not be taking female sex hormones (estrogen with or without progesterone,or their derivatives); FSAD, defined as the inability, persistent or recurrent, to obtain or maintain untilthe conclusion of sexual activity an adequate genital response to sexual arousal (lubrication, warmth and enlargement of the clitoris); FSAD, defined as the inability, persistent or recurrent, to obtain or maintain untilthe conclusion of sexual activity an adequate genital response to sexual arousal (lubrication, warmth and enlargement of the clitoris); Women with FSAD who present marked suffering or interpersonal difficulties; Women with FSAD who present marked suffering or interpersonal difficulties; Stable relationship for more than 6 months, with a sexually active partner; Stable relationship for more than 6 months, with a sexually active partner; Ability to read and understand the Informed Consent Form (ICF) and to answer thequestionnaires. Ability to read and understand the Informed Consent Form (ICF) and to answer thequestionnaires. Women who do not agree to use a contraceptive method and who have the capacity tobecome pregnant during the study; Women who do not agree to use a contraceptive method and who have the capacity tobecome pregnant during the study; Women who do not agree to attempt sexual activity at least twice a week while takingthe study medication; Women who do not agree to attempt sexual activity at least twice a week while takingthe study medication; History of unresolved sexual trauma or abuse; History of unresolved sexual trauma or abuse; Diagnosis of vaginismus, genitopelvic pain/penetration disorder and/or sexualaversion disorder; Diagnosis of vaginismus, genitopelvic pain/penetration disorder and/or sexualaversion disorder; Uncontrolled diabetes at screening visit (HbA1C > 10%); Uncontrolled diabetes at screening visit (HbA1C > 10%); Prior spinal cord injury, with lower limb paralysis; Prior spinal cord injury, with lower limb paralysis; History of abdominal or pelvic surgery that may have damaged pelvic nerves,including vulvectomy, colostomy, cytostomy, hysterectomy, or bladder suspension. History of abdominal or pelvic surgery that may have damaged pelvic nerves,including vulvectomy, colostomy, cytostomy, hysterectomy, or bladder suspension. Current testosterone use, or long-term testosterone use (such as chip) within thepast 6 months; Current testosterone use, or long-term testosterone use (such as chip) within thepast 6 months; Presence of menstrual irregularity or endocrinopathies that significantly alter themenstrual cycle, preventing Cytocam analyses from taking place at the same time; Presence of menstrual irregularity or endocrinopathies that significantly alter themenstrual cycle, preventing Cytocam analyses from taking place at the same time; Patients with current depression, characterized by the use or need for use ofpsychotropic drugs, including bupropion, lithium, or neuroleptics; Patients with current depression, characterized by the use or need for use ofpsychotropic drugs, including bupropion, lithium, or neuroleptics; Presence of genital lesions that impair analysis of local adverse effects on thegenitalia; Presence of genital lesions that impair analysis of local adverse effects on thegenitalia; Presence of diseases that cause excessive vaginal discharge, such as recurrenturinary tract infection, vaginal infection and pelvic inflammatory disease.

Tadalafil and insulin sensitivity: why it matters for muscle gain

Presence of diseases that cause tadalafil sale excessive vaginal discharge, such as recurrenturinary tract infection, vaginal infection and pelvic inflammatory disease. Abnormal Papanicolaou test within the past 3 years; Abnormal Papanicolaou test within the past 3 years; History of gynecological cancer (history of uterine dysplasia can be included,provided it has been properly treated for at least 6 months); History of gynecological cancer (history buy tadalafil of uterine dysplasia can be included,provided it has been properly treated for at least 6 months); Use of topical medications in the genital region that may interfere with PSIassessment as well as their absorption or drug interaction, including vaginalestrogens, lubricants, spermicides, creams or gels, vaginal douches; Use of topical medications in the genital region that may interfere with PSIassessment as well as their absorption or drug interaction, including vaginalestrogens, lubricants, spermicides, creams or gels, vaginal douches; History of symptomatic hypotension, or diseases that increase the risk ofsymptomatic hypotension, such as patient with heart disease (including history ofangina and/or heart failure) and nephropathies; History of symptomatic hypotension, or diseases that increase the risk ofsymptomatic hypotension, such as patient with heart disease (including history ofangina and/or heart failure) and nephropathies; Current use of nitrates, such as propatylnitrate (Sustrate®), isosorbide (Monocordil®, Cincordil®, Isordil®), nitroglycerin (Nitradisc®, Nitroderm TTS®,Nitronal®, Tridil®) and sosorbitol dinitrate (Isocord®) Current use of nitrates, such as propatylnitrate (Sustrate®), isosorbide (Monocordil®, Cincordil®, Isordil®), nitroglycerin (Nitradisc®, Nitroderm TTS®,Nitronal®, Tridil®) and sosorbitol dinitrate (Isocord®) ECG findings that are clinically symptomatic, or that, in the Investigator'sjudgment, are considered significant and pose a risk to the research volunteer'sparticipation; ECG findings that are clinically symptomatic, or that, in the Investigator'sjudgment, are considered significant and pose a risk to the research volunteer'sparticipation; Findings on laboratory tests that, in the Investigator's judgment, are consideredsignificant and offer risk to the research volunteer's participation or may hinderthe study analyses; Findings on laboratory tests that, in the Investigator's judgment, are consideredsignificant and offer risk to the research volunteer's participation or may hinderthe study analyses; TSH outside normal limits for age (participants with hypothyroidism on stable doseof medication, over 3 months, may be included); TSH outside normal limits for age (participants with hypothyroidism on stable doseof medication, over 3 months, may be included); BP outside safe limits: SBP below 90 mmHg or above 170 mmHg; or DBP below 50 mmHg orabove 100 mmHg, except for situations such as "white coat" syndrome BP outside safe limits: SBP below 90 mmHg or above 170 mmHg; or DBP below 50 mmHg orabove 100 mmHg, except for situations such as "white coat" syndrome Severe hypertension, considered as use of three or more antihypertensives; Severe hypertension, considered as use of three or more antihypertensives; Diseases that can cause clitoral priapism, such as sickle cell anemia, multiplemyeloma or leukemia; Diseases that can cause clitoral priapism, such as sickle cell anemia, multiplemyeloma or leukemia; Current relevant diarrhea, defined as duration over four weeks, association withabdominal pain or malabsorptive syndrome, or presence of mucus, pus, or blood in thestool; Current relevant diarrhea, defined as duration over four weeks, association withabdominal pain or malabsorptive syndrome, or presence of mucus, pus, or blood in thestool; Current use of nitric oxide donors, guanylate cyclase stimulators (e.g. Riociguat),or 5- phosphodiesterase inhibitors (Sildenafil, Tadalafil, etc.); Any disease or condition or physical finding that the Investigator considerssignificant and that increases the risk of the research participant's participationor may interfere with the results, including serious debilitating diseases, presenceof cancer, serious mental illness, persistent abuse of medication. Any disease or condition or physical finding that the Investigator considerssignificant and that increases the risk of the research participant's participationor may interfere with the results, 10mg tadalafil including serious debilitating diseases, presenceof cancer, serious mental illness, persistent abuse of medication. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.